• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在马来西亚国民大学医学中心确诊的患者中α地中海贫血的分子特征

Molecular characteristic of alpha thalassaemia among patients diagnosed in UKM Medical Centre.

作者信息

Azma Raja Zahratul, Ainoon Othman, Hafiza Alauddin, Azlin Ithnin, Noor Farisah Abudul Razak, Nor Hidayati Sardi, Noor Hamidah Hussin

机构信息

Universiti Kebangsaan Malaysia Medical Centre (UKMMC), Department of Pathology, Jalan Yaacob Latif, Bandar Tun Razak, 56000 Kuala Lumpur, Malaysia.

出版信息

Malays J Pathol. 2014 Apr;36(1):27-32.

PMID:24763232
Abstract

Alpha (Α) thalassaemia is the most common inherited disorder in Malaysia. The clinical severity is dependant on the number of Α genes involved. Full blood count (FBC) and haemoglobin (Hb) analysis using either gel electrophoresis, high performance liquid chromatography (HPLC) or capillary zone electrophoresis (CE) are unable to detect definitively alpha thalassaemia carriers. Definitive diagnosis of Α-thalassaemias requires molecular analysis and methods of detecting both common deletional and non-deletional molecular abnormailities are easily performed in any laboratory involved in molecular diagnostics. We carried out a retrospective analysis of 1623 cases referred to our laboratory in Universiti Kebangsaan Malaysia Medical Centre (UKMMC) for the diagnosis of Α-thalassaemia during the period October 2001 to December 2012. We examined the frequency of different types of alpha gene abnormalities and their haematologic features. Molecular diagnosis was made using a combination of multiplex polymerase reaction (PCR) and real time PCR to detect deletional and non-deletional alpha genes relevant to southeast Asian population. Genetic analysis confirmed the diagnosis of Α-thalassaemias in 736 cases. Majority of the cases were Chinese (53.1%) followed by Malays (44.2%), and Indians (2.7%). The most common gene abnormality was ΑΑ/--(SEA) (64.0%) followed by ΑΑ/-Α(3.7) (19.8%), -Α(3.7) /--(SEA) (6.9%), ΑΑ/ΑΑCS (3.0%), --(SEA)/--(SEA) (1.2%), -Α(3.7)/-Α(3.7) (1.1%), ΑΑ/-Α(4.2) (0.7%), -Α(4.2)/--(SEA (0.7%), -Α(3.7)/-Α(4.2) (0.5%), ΑΑ(CS)/-- SEA) (0.4%), ΑΑ(CS)/ΑΑ(Cd59) (0.4%), ΑΑ(CS)/ΑΑ(CS) (0.4%), -Α(3.7)/ΑΑ(Cd59) (0.3%), ΑΑ/ΑΑ(Cd59) (0.1%), ΑΑ(Cd59)/ ΑΑ(IVS I-1) (0.1%), -Α(3.7)/ΑΑ(CS) (0.1%) and --(SEA) /ΑΑ(Cd59) (0.1%). This data indicates that the molecular abnormalities of Α-thalassaemia in the Malaysian population is heterogenous. Although Α-gene deletion is the most common cause, non-deletional Α-gene abnormalities are not uncommon and at least 3 different mutations exist. Establishment of rapid and easy molecular techniques is important for definitive diagnosis of alpha thalassaemia, an important prerequisite for genetic counselling to prevent its deleterious complications.

摘要

α地中海贫血是马来西亚最常见的遗传性疾病。临床严重程度取决于受累α基因的数量。全血细胞计数(FBC)和使用凝胶电泳、高效液相色谱(HPLC)或毛细管区带电泳(CE)的血红蛋白(Hb)分析无法明确检测出α地中海贫血携带者。α地中海贫血的确切诊断需要分子分析, 并且在任何从事分子诊断的实验室中都能轻松进行检测常见缺失和非缺失分子异常的方法。我们对2001年10月至2012年12月期间转诊至马来西亚国民大学医学中心(UKMMC)我们实验室进行α地中海贫血诊断的1623例病例进行了回顾性分析。我们检查了不同类型α基因异常的频率及其血液学特征。使用多重聚合酶反应(PCR)和实时PCR组合进行分子诊断,以检测与东南亚人群相关的缺失和非缺失α基因。基因分析确诊了736例α地中海贫血病例。大多数病例是华人(53.1%),其次是马来人(44.2%)和印度人(2.7%)。最常见的基因异常是αα/--(SEA)(64.0%),其次是αα/-α(3.7)(19.8%)、-α(3.7)/--(SEA)(6.9%)、αα/ααCS(3.0%)、--(SEA)/--(SEA)(1.2%)、-α(3.7)/-α(3.7)(1.1%)、αα/-α(4.2)(0.7%)、-α(4.2)/--(SEA)(0.7%)、-α(3.7)/-α(4.2)(0.5%)、αα(CS)/--SEA(0.4%)、αα(CS)/αα(Cd59)(0.4%)、αα(CS)/αα(CS)(0.4%)、-α(3.7)/αα(Cd59)(0.3%)、αα/αα(Cd59)(0.1%)、αα(Cd59)/αα(IVS I-1)(0.1%)、-α(3.7)/αα(CS)(0.1%)和--(SEA)/αα(Cd59)(0.1%)。该数据表明马来西亚人群中α地中海贫血的分子异常是异质性的。虽然α基因缺失是最常见的原因,但非缺失性α基因异常并不罕见,并且至少存在3种不同的突变。建立快速简便的分子技术对于α地中海贫血的确切诊断很重要,这是进行遗传咨询以预防其有害并发症的重要前提。

相似文献

1
Molecular characteristic of alpha thalassaemia among patients diagnosed in UKM Medical Centre.在马来西亚国民大学医学中心确诊的患者中α地中海贫血的分子特征
Malays J Pathol. 2014 Apr;36(1):27-32.
2
Thalassemia intermedia in HbH-CS disease with compound heterozygosity for beta-thalassemia: challenges in hemoglobin analysis and clinical diagnosis.血红蛋白H-Constant Spring病合并β地中海贫血复合杂合子状态的中间型地中海贫血:血红蛋白分析及临床诊断中的挑战
Genes Genet Syst. 2009 Feb;84(1):67-71. doi: 10.1266/ggs.84.67.
3
Prevalence of α-thalassaemia genotypes in pregnant women in northern Thailand.泰国北部孕妇中α地中海贫血基因型的患病率。
Indian J Med Res. 2016 Mar;143(3):315-22. doi: 10.4103/0971-5916.182622.
4
Analysis of α1 and α2 globin genes among patients with hemoglobin Adana in Malaysia.马来西亚血红蛋白阿达纳患者中α1和α2珠蛋白基因分析。
Genet Mol Res. 2016 Apr 7;15(2):gmr7400. doi: 10.4238/gmr.15027400.
5
A rare case of compound heterozygous Southeast Asian double α-globin gene deletion and Haemoglobin Quong Sze in a Malay proband.一个马来先证者中罕见的复合杂合东南亚双重α-珠蛋白基因缺失和 Hb Quong Sze 病例。
Malays J Pathol. 2024 Aug;46(2):321-324.
6
A laboratory strategy for genotyping haemoglobin H disease in the Chinese.一种针对中国人血红蛋白H病基因分型的实验室策略。
J Clin Pathol. 2007 Aug;60(8):931-4. doi: 10.1136/jcp.2006.042242. Epub 2006 Oct 3.
7
Heterogeneity in alpha-thalassemia interactions in Malays, Chinese and Indians in Malaysia.马来西亚马来人、华人及印度人中α地中海贫血相互作用的异质性。
J Obstet Gynaecol Res. 2005 Dec;31(6):540-6. doi: 10.1111/j.1447-0756.2005.00333.x.
8
Gene Mutation Spectrum among Alpha-Thalassaemia Patients in Northeast Peninsular Malaysia.马来西亚半岛东北部α地中海贫血患者的基因突变谱
Diagnostics (Basel). 2023 Feb 27;13(5):894. doi: 10.3390/diagnostics13050894.
9
Alpha-thalassaemia in association with beta-thalassaemia patients in Malaysia: a study on the co-inheritance of both disorders.马来西亚α地中海贫血合并β地中海贫血患者:两种疾病共同遗传的研究。
Community Genet. 2008;11(3):129-34. doi: 10.1159/000113874. Epub 2008 Mar 26.
10
High-resolution melting analysis of the three common nondeletional α-thalassemia mutations in the Chinese population: Hbs Constant Spring, Quong Sze and Westmead.中国人群中三种常见非缺失型α地中海贫血突变(血红蛋白Constant Spring、Quong Sze和Westmead)的高分辨率熔解分析
Hemoglobin. 2010;34(6):587-93. doi: 10.3109/03630269.2010.526881.

引用本文的文献

1
The Clinical and Laboratory Profiles of a Deletional α2-Globin Gene Polyadenylation Signal Sequence (AATAAA > AATA--) [HBA2:c.*93_*94delAA]: The Malaysian Experience.缺失型α2-珠蛋白基因多聚腺苷酸化信号序列(AATAAA > AATA--)[HBA2:c.*93_*94delAA]的临床和实验室特征:马来西亚的经验
Diagnostics (Basel). 2025 May 20;15(10):1284. doi: 10.3390/diagnostics15101284.
2
A rare hemoglobinopathy duo: Hb Adana×Hb SEA in a 1-year-old patient - a case report and a brief literature review.一例罕见的血红蛋白病组合:1岁患儿的Hb Adana×Hb SEA——病例报告及文献简要综述
Ann Med Surg (Lond). 2024 Apr 29;86(6):3730-3735. doi: 10.1097/MS9.0000000000002101. eCollection 2024 Jun.
3
Hematological Profile of Hb Adana Among High School Students in Northeast Peninsular Malaysia.
马来西亚东北半岛高中生中阿德纳血红蛋白的血液学特征
Cureus. 2024 Mar 31;16(3):e57353. doi: 10.7759/cureus.57353. eCollection 2024 Mar.
4
Characterization of New Alpha Zero (α) Thalassaemia Deletion (--) among Malays in Malaysian Population.马来西亚人群中马来人新型缺失型(--)α地中海贫血的特征分析
Diagnostics (Basel). 2023 Oct 23;13(20):3286. doi: 10.3390/diagnostics13203286.
5
Application of Targeted Next-Generation Sequencing for the Investigation of Thalassemia in a Developing Country: A Single Center Experience.靶向新一代测序技术在发展中国家地中海贫血调查中的应用:单中心经验
Diagnostics (Basel). 2023 Apr 10;13(8):1379. doi: 10.3390/diagnostics13081379.
6
A Novel Algorithm Using Cell Population Data (VCS Parameters) as a Screening Discriminant between Alpha and Beta Thalassemia Traits.一种使用细胞群体数据(VCS参数)作为α与β地中海贫血特征筛查判别指标的新型算法。
Diagnostics (Basel). 2021 Nov 22;11(11):2163. doi: 10.3390/diagnostics11112163.
7
Prevalence of Alpha(α)-Thalassemia in Southeast Asia (2010-2020): A Meta-Analysis Involving 83,674 Subjects.东南亚地区α-地中海贫血症的患病率(2010-2020 年):一项涉及 83674 例患者的荟萃分析。
Int J Environ Res Public Health. 2020 Oct 9;17(20):7354. doi: 10.3390/ijerph17207354.
8
The first report of hemoglobin E in combination with the highly unstable alpha-globin variant Hb Adana: The importance of molecular confirmation.血红蛋白E与高度不稳定的α-珠蛋白变体Hb Adana联合的首次报道:分子确认的重要性。
Int J Lab Hematol. 2019 Jun;41(3):e76-e78. doi: 10.1111/ijlh.12965. Epub 2019 Jan 20.
9
DNA studies are necessary for accurate patient diagnosis in compound heterozygosity for Hb Adana (HBA2:c.179>A) with deletional or nondeletional α-thalassaemia.对于患有Hb Adana(HBA2:c.179>A)复合杂合子且伴有缺失型或非缺失型α地中海贫血的患者,进行DNA研究对于准确诊断是必要的。
Sci Rep. 2016 Jun 8;6:26994. doi: 10.1038/srep26994.